SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Strategies & Market Trends : HOW MUCH MONEY IS YOUR GOAL???

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Stonehenge who wrote (385)5/16/1997 7:23:00 PM
From: JPR   of 470
 
<<<< Do you like Pfizer too???>>>

Sorry for the intrusion.

I will keep it short!

1: Sales rose 12% in the March qtr.
2: Top-line drugs: Norvosac, Glucotrol x-L, Diflucan, Zithromax, Zoloft, Cardura accounting for 70% of total sales.
3: Zyrtec Sales (antihistamine)in march about $50 mil.
Remember the add: the man climbing the mountain and dangling on a rope without any worry or dizziness)
4: New launch: Aricept for Alzheimer's
5: Lipitor Cholesterol reduction
4 & 5 well received
6: Broad-spectrum antibiotic TROVAN drug application filed.
Sales may begin in 1998.
7: other drugs in the pipeline: Viagra for impotence, and more.
8: annual growth in share profits expected around 15%.


Appealing candidate for your portfolio

PJ
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext